• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Catalog Number GSXE0030
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Endocarditis (1834); Thrombosis/Thrombus (4440)
Event Date 04/15/2021
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing records for the device verified that the lot met all prerelease specifications.Device evaluated by mfr: engineering evaluation could not be performed as the device remains implanted.(b)(4).
 
Event Description
It was reported to gore that a 30mm gore¿ cardioform septal occluder was intended to be used to treat a patient with patent foramen ovale.The implantation procedure on (b)(6) 2021 was fine.The patient received heparin during the procedure and antibiotics (cefasolin 2gr) was administered.One day post-implant in the morning of (b)(6), the echocardiogram results were fine and the device looked ok.In the evening it was reported that the patient had a temperature of 37.8 degrees and received antibiotics (cefixsoral 400 x 2).On (b)(6), the patient suffered from fever at 39 degrees and shivers.On (b)(6), echocardiogram showed a thrombotic mass on the right side on the disc.The physicians started antibiotic therapy for endocarditis (tazocin + daptomycin).In the meantime aspirin and plavix have been suspended, and anticoagulation was started.The fever was gone on (b)(6), the following values where documented: pcr max 7, procalcutonin 0, white blood cells peak 12,500 then 8,500 (decreasing), no symptoms, no organ recall.The blood cultures results are negative.It was reported that the patient is asymptomatic and fever free since (b)(6) 2021.Fluroroscopy showed that the occluder device is perfect in site on (b)(6) 2021.Echocardiogram showed vegetation/mass on both left and right.Values pcr 1.3, and white blobs 10,700 were documented.It is not yet decided if the device will be removed surgically.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
ida simson
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key11841508
MDR Text Key251195950
Report Number2017233-2021-02015
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 05/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/18/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/03/2023
Device Catalogue NumberGSXE0030
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/21/2021
Date Device Manufactured11/03/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age29 YR
-
-